Vitamin D and immune function: An overview

Proceedings of the Nutrition Society

Volumn 71, Issue 1, 2012, Pages 50-61

  Hewison, Martin ^a  

^a JOINT REPLACEMENT INSTITUTE   (United States)

Author keywords

Adaptive immunity; Antibacterial; Innate immunity; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; VITAMIN D;

ADAPTIVE IMMUNITY; ADOLESCENT; ANTIBACTERIAL ACTIVITY; ANTIGEN PRESENTING CELL; CELL MATURATION; CONFERENCE PAPER; CROHN DISEASE; DENDRITIC CELL; ENTERITIS; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE FUNCTION; MACROPHAGE; MULTIPLE SCLEROSIS; NONHUMAN; PREGNANCY; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TUBERCULOSIS; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

AUTOIMMUNE DISEASES; DENDRITIC CELLS; HUMANS; IMMUNITY; IMMUNOLOGIC FACTORS; INFECTION; MACROPHAGES; T-LYMPHOCYTES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84856250752     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665111001650     Document Type: Conference Paper

References (152)

1. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357, 266-281.
2. Chapuy MC, Preziosi P, Maamer M et al. (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7, 439-443. (Pubitemid 27443069)
3. Heaney RP, Dowell MS, Hale CA et al. (2003) Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22, 142-146. (Pubitemid 36417827)
4. Holick MF (2009) Vitamin D status: Measurement, interpretation, and clinical application. Ann Epidemiol 19, 73-78.
5. Mithal A, Wahl DA, Bonjour JP et al. (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20, 1807-1820.
6. Dawson-Hughes B, Heaney RP, Holick MF et al. (2005) Estimates of optimal vitamin D status. Osteoporos Int 16, 713-716. (Pubitemid 40933586)
7. Spina CS, Tangpricha V, Uskokovic M et al. (2006) Vitamin D and cancer. Anticancer Res 26, 2515-2524. (Pubitemid 44155530)
8. Zittermann A (2006) Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 92, 39-48. (Pubitemid 43831966)
9. Adams JS & Hewison M Update in vitamin D. J Clin Endocrinol Metab 95, 471-478.
10. Adams JS & Hewison M (2008) Unexpected actions of vitamin D: New perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 4, 80-90. (Pubitemid 351156900)
11. Schuster I (2011) Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta 1814, 186-199.
12. Zehnder D, Bland R, Walker EA et al. (1999) Expression of 25-hydroxyvitamin D3-1a-hydroxylase in the human kidney. J Am Soc Nephrol 10, 2465-2473.
13. Liu S & Quarles LD (2007) How fibroblast growth factor 23 works. J Am Soc Nephrol 18, 1637-1647. (Pubitemid 46870300)
14. Yamazaki Y, Tamada T, Kasai N et al. (2008) Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23. J Bone Miner Res 23, 1509-1518.
15. Yoshiko Y, Wang H, Minamizaki T et al. (2007) Mineralized tissue cells are a principal source of FGF23. Bone 40, 1565-1573. (Pubitemid 46756409)
16. Fukumoto S (2008) Physiological regulation and disorders of phosphate metabolism-pivotal role of fibroblast growth factor 23. Intern Med 47, 337-343. (Pubitemid 351663682)
17. Razzaque MS (2009) Does FGF23 toxicity influence the outcome of chronic kidney disease? Nephrol Dial Transplant 24, 4-7.
18. Omdahl JMB (2005) The 25-hydroxyvitamin D-24-hydroxylase. New York: Elsevier.
19. Haussler MR, Haussler CA, Bartik L et al. (2008) Vitamin D receptor: Molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev 66, S98-S112.
20. Jurutka PW, Bartik L, Whitfield GK et al. (2007) Vitamin D receptor: Key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. J Bone Miner Res 22, Suppl 2, V2-V10. (Pubitemid 351304640)
21. Holick MF (2006) Vitamin D: Its role in cancer prevention and treatment. Prog Biophys Mol Biol 92, 49-59. (Pubitemid 43831958)
22. Zhou C, Lu F, Cao K et al. (2008) Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1a-hydroxylase knockout mice. Kidney Int 74, 170-179. (Pubitemid 351915078)
23. Li YC, Kong J, Wei M et al. (2002) 1,25-dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110, 229-238. (Pubitemid 34787360)
24. Hewison M (2011) Vitamin D and innate and adaptive immunity. Vitam Horm 86, 23-62.
25. Hewison M Antibacterial effects of vitamin D. Nat Rev Endocrinol 7, 337-345.
26. Adams JS & Gacad MA (1985) Characterization of 1a-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 161, 755-765. (Pubitemid 15083775)
27. Papapoulos SE, Clemens TL, Fraher LJ et al. (1979) 1,25- dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis. Lancet 1, 627-630.
28. Hewison M, Burke F, Evans KN et al. (2007) Extra-renal 25-hydroxyvitamin D3-1a-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 103, 316-321. (Pubitemid 46420518)
29. Zehnder D, Bland R, Williams MC et al. (2001) Extrarenal expression of 25-hydroxyvitamin D(3)-1a-hydroxylase. J Clin Endocrinol Metab 86, 888-894.
30. Gray TK, Lester GE & Lorenc RS (1979) Evidence for extra-renal 1a-hydroxylation of 25-hydroxyvitamin D3 in pregnancy. Science 204, 1311-1313. (Pubitemid 9223718)
31. Weisman Y, Harell A, Edelstein S et al. (1979) 1a,25-Dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta. Nature 281, 317-319. (Pubitemid 10225344)
32. Zehnder D, Evans KN, Kilby MD et al. (2002) The ontogeny of 25-hydroxyvitamin D(3) 1a-hydroxylase expression in human placenta and decidua. Am J Pathol 161, 105-114. (Pubitemid 34760776)
33. Evans KN, Bulmer JN, Kilby MD et al. (2004) Vitamin D and placental-decidual function. J Soc Gynecol Investig 11, 263-271. (Pubitemid 38833606)
34. Vanhooke JL, Prahl JM, Kimmel-Jehan C et al. (2006) CYP27B1 null mice with LacZ reporter gene display no 25-hydroxyvitamin D3-1a-hydroxylase promoter activity in the skin. Proc Natl Acad Sci USA 103, 75-80. (Pubitemid 43076107)
35. Novakovic B, Sibson M, Ng HK et al. (2009) Placentaspecific methylation of the vitamin D 24-hydroxylase gene: Implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J Biol Chem 284, 14838-14848.
36. Kovacs CS & Kronenberg HM (1997) Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 18, 832-872. (Pubitemid 28009569)
37. Jones G, Strugnell SA & DeLuca HF (1998) Current understanding of the molecular actions of vitamin D. Physiol Rev 78, 1193-1231. (Pubitemid 28491953)
38. Townsend K, Evans KN, Campbell MJ et al. (2005) Biological actions of extra-renal 25-hydroxyvitamin D-1ahydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol 97, 103-109. (Pubitemid 41546219)
39. Peterlik M & Cross HS (2006) Dysfunction of the vitamin D endocrine system as common cause for multiple malignant and other chronic diseases. Anticancer Res 26, 2581-2588. (Pubitemid 44155538)
40. Cross HS, Kallay E, Farhan H et al. (2003) Regulation of extrarenal vitamin D metabolism as a tool for colon and prostate cancer prevention. Recent Results Cancer Res 164, 413-425.
41. Li M & Batuman V (2009) Vitamin D: A new hope for chronic kidney disease? Kidney Int 76, 1219-1221.
42. Rook GA, Steele J, Fraher L et al. (1986) Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 57, 159-163. (Pubitemid 16232232)
43. Epstein S, Stern PH, Bell NH et al. (1984) Evidence for abnormal regulation of circulating 1a,25-dihydroxyvitamin D in patients with pulmonary tuberculosis and normal calcium metabolism. Calcif Tissue Int 36, 541-544. (Pubitemid 15157106)
44. Bell NH, Shary J, Shaw S et al. (1985) Hypercalcemia associated with increased circulating 1,25-dihydroxyvitamin D in a patient with pulmonary tuberculosis. Calcif Tissue Int 37, 588-591. (Pubitemid 16197163)
45. Liu PT, Stenger S, Li H et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770-1773.
46. Zaiou M & Gallo RL (2002) Cathelicidins, essential geneencoded mammalian antibiotics. J Mol Med 80, 549-561.
47. Zanetti M (2004) Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75, 39-48. (Pubitemid 38166778)
48. Wang TT, Nestel FP, Bourdeau V et al. (2004) Cutting edge: 1,25-DihydroxyvitaminD3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173, 2909-2912. (Pubitemid 39141992)
49. Gombart AF, Borregaard N & Koeffler HP (2005) Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 19, 1067-1077. (Pubitemid 40946432)
50. Gombart AF, Saito T & Koeffler HP (2009) Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates. BMC Genomics 10, 321.
51. Adams JS, Ren S, Liu PT et al. (2009) Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 182, 4289-4295.
52. Liu PT, Schenk M, Walker VP et al. (2009) Convergence of IL-1b and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS ONE 4, e5810.
53. Wang TT, Dabbas B, Laperriere D et al. (2010) Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin b2 innate immune pathway defective in Crohn disease. J Biol Chem 285, 2227-2231.
54. Klionsky DJ & Emr SD (2000) Autophagy as a regulated pathway of cellular degradation. Science 290, 1717-1721. (Pubitemid 32004796)
55. Levine B & Deretic V (2007) Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol 7, 767-777. (Pubitemid 47480305)
56. Yuk JM, Shin DM, Lee HM et al. (2009) Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 6, 231-243.
57. Shin DM, Yuk JM, Lee HM et al. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cell Microbiol 12, 1648-1665.
58. Yim S, Dhawan P, Ragunath C et al. (2007) Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J Cyst Fibros 6, 403-410. (Pubitemid 350028703)
59. Evans KN, Nguyen L, Chan J et al. (2006) Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol Reprod 75, 816-822. (Pubitemid 44845586)
60. Liu N, Kaplan AT, Low J et al. (2009) Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol Reprod 80, 398-406.
61. Schauber J, Dorschner RA, Yamasaki K et al. (2006) Control of the innate epithelial antimicrobial response is celltype specific and dependent on relevant microenvironmental stimuli. Immunology 118, 509-519. (Pubitemid 44079569)
62. Schauber J, Dorschner RA, Coda AB et al. (2007) Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 117, 803-811. (Pubitemid 46348539)
63. Wang TT, Dabbas B, Laperriere D et al. (2009) Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-b defensin 2 innate immune pathway defective in Crohn's disease. J Biol Chem 285, 2227-2231.
64. Brennan A, Katz DR, Nunn JD et al. (1987) Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology 61, 457-461. (Pubitemid 17127352)
65. Penna G & Adorini L (2000) 1a,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164, 2405-2411. (Pubitemid 30115468)
66. Adorini L, Penna G, Giarratana N et al. (2003) Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J Cell Biochem 88, 227-233. (Pubitemid 36119891)
67. Penna G, Amuchastegui S, Giarratana N et al. (2007) 1,25-dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol 178, 145-153. (Pubitemid 46033595)
68. Hewison M, Freeman L, Hughes SV et al. (2003) Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 170, 5382-5390. (Pubitemid 36617823)
69. Griffin MD, Lutz W, Phan VA et al. (2001) Dendritic cell modulation by 1a,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 98, 6800-6805. (Pubitemid 32538297)
70. Panda DK, Miao D, Tremblay ML et al. (2001) Targeted ablation of the 25-hydroxyvitamin D 1a-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci USA 98, 7498-7503. (Pubitemid 32567977)
71. Enioutina EY, Bareyan D & Daynes RA (2009) TLRinduced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses. J Immunol 182, 4296-4305.
72. Grad R (2004) Cod and the consumptive: A brief history of cod-liver oil in the treatment of pulmonary tuberculosis. Pharm Hist 46, 106-120.
73. Wilkinson RJ, Llewelyn M, Toossi Z et al. (2000) Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: A case-control study. Lancet 355, 618-621. (Pubitemid 30099469)
74. Ustianowski A, Shaffer R, Collin S et al. (2005) Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J Infect 50, 432-437. (Pubitemid 40692029)
75. Williams B, Williams AJ & Anderson ST (2008) Vitamin D deficiency and insufficiency in children with tuberculosis. Pediatr Infect Dis J 27, 941-942.
76. Wejse C, Gomes VF, Rabna P et al. (2009) Vitamin D as supplementary treatment for tuberculosis: A double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 179, 843-850.
77. Martineau AR, Wilkinson RJ, Wilkinson KA et al. (2007) A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 176, 208-213. (Pubitemid 47057859)
78. Nursyam EW, Amin Z & Rumende CM (2006) The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 38, 3-5.
79. Martineau AR, Timms PM, Bothamley GH et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: A double-blind randomised controlled trial. Lancet 377, 242-250.
80. Chun RF, Lauridsen AL, Suon L et al. (2010) Vitamin D-binding protein directs monocyte responses to 25-hydroxy-and 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab 95, 3368-3376.
81. Lauridsen AL, Vestergaard P, Hermann AP et al. (2005) Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): A cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int 77, 15-22. (Pubitemid 41504168)
82. Arnaud J & Constans J (1993) Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet 92, 183-188. (Pubitemid 23272286)
83. Nykjaer A, Dragun D, Walther D et al. (1999) An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96, 507-515. (Pubitemid 29106838)
84. Jeng L, Yamshchikov AV, Judd SE et al. (2009) Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 7, 28.
85. Gombart AF, Bhan I, Borregaard N et al. (2009) Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clin Infect Dis 48, 418-424.
86. Cannell JJ, Vieth R, Umhau JC et al. (2006) Epidemic influenza and vitamin D. Epidemiol Infect 134, 1129-1140. (Pubitemid 44614932)
87. Hooper LV, Stappenbeck TS, Hong CV et al. (2003) Angiogenins: A new class of microbicidal proteins involved in innate immunity. Nat Immunol 4, 269-273. (Pubitemid 36322137)
88. Packey CD & Sartor RB (2009) Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis 22, 292-301.
89. Masoumi A, Goldenson B, Ghirmai S et al. (2009) 1a,25-Dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-b clearance by macrophages of Alzheimer's disease patients. J Alzheimers Dis 17, 703-717.
90. Stoffels K, Overbergh L, Giulietti A et al. (2006) Immune regulation of 25-hydroxyvitamin-D(3)-1a-hydroxylase in human monocytes. J Bone Miner Res 21, 37-47. (Pubitemid 43023225)
91. Krutzik SR, Hewison M, Liu PT et al. (2008) IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol 181, 7115-7120.
92. Edfeldt K, Liu PT, Chun R et al. (2010) T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci USA 107, 22593-22598.
93. Peelen E, Knippenberg S, Muris AH et al. (2011) Effects of vitamin D on the peripheral adaptive immune system: A review. Autoimmun Rev. Epublication ahead of print.
94. Bhalla AK, Amento EP, Clemens TL et al. (1983) Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: Presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 57, 1308-1310. (Pubitemid 14209439)
95. Provvedini DM, Tsoukas CD, Deftos LJ et al. (1983) 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 221, 1181-1183.
96. Nunn JD, Katz DR, Barker S et al. (1986) Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3. Immunology 59, 479-484. (Pubitemid 17178266)
97. Provvedini DM & Manolagas SC (1989) 1a,25-Dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes. J Clin Endocrinol Metab 68, 774-779. (Pubitemid 19089008)
98. Karmali R, Hewison M, Rayment N et al. (1991) 1,25(OH)2D3 regulates c-myc mRNA levels in tonsillar T lymphocytes. Immunology 74, 589-593.
99. Lemire JM, Archer DC, Beck L et al. (1995) Immunosuppressive actions of 1,25-dihydroxyvitamin D3: Preferential inhibition of Th1 functions. J Nutr 125, 1704S-1708S.
100. Overbergh L, Decallonne B, Waer M et al. (2000) 1a,25-Dihydroxyvitamin D3 induces an autoantigen-specific Thelper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 49, 1301-1307. (Pubitemid 30624229)
101. Boonstra A, Barrat FJ, Crain C et al. (2001) 1a,25-Dihydroxyvitamin D3 has a direct effect on naive CD4( +) T cells to enhance the development of Th2 cells. J Immunol 167, 4974-4980. (Pubitemid 33009728)
102. O'Kelly J, Hisatake J, Hisatake Y et al. (2002) Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. J Clin Invest 109, 1091-1099. (Pubitemid 34408584)
103. Harrington LE, Mangan PR & Weaver CT (2006) Expanding the effector CD4 T-cell repertoire: The Th17 lineage. Curr Opin Immunol 18, 349-356.
104. Weaver CT, Hatton RD, Mangan PR et al. (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25, 821-852. (Pubitemid 46697925)
105. Bettelli E, Korn T & Kuchroo VK (2007) Th17: The third member of the effector T cell trilogy. Curr Opin Immunol 19, 652-657. (Pubitemid 350236805)
106. Korn T, Oukka M, Kuchroo V et al. (2007) Th17 cells: Effector T cells with inflammatory properties. Semin Immunol 19, 362-371. (Pubitemid 351274046)
107. Colin EM, Asmawidjaja PS, van Hamburg JP et al. (2010) 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 62, 132-142.
108. Palmer MT, Lee YK, Maynard CL et al. (2010) Lineagespecific effects of 1,25-dihydroxyvitamin D(3) on the development of effector CD4 T cells. J Biol Chem 286, 997-1004.
109. Chang SH, Chung Y & Dong C (2010) Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression. J Biol Chem 285, 38751-38755.
110. Daniel C, Sartory NA, Zahn N et al. (2007) Immune modulatory treatment of TNBS colitis with calcitriol is associated with a change of a Th1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 324, 23-33. (Pubitemid 350294165)
111. Liu N, Nguyen L, Chun RF et al. (2008) Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology 149, 4799-4808.
112. Gorman S, Kuritzky LA, Judge MA et al. (2007) Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4 + CD25 + cells in the draining lymph nodes. J Immunol 179, 6273-6283.
113. Gregori S, Giarratana N, Smiroldo S et al. (2002) A 1a,25- dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51, 1367-1374. (Pubitemid 34826601)
114. Mathieu C & Badenhoop K (2005) Vitamin D and type 1 diabetes mellitus: State of the art. Trends Endocrinol Metab 16, 261-266. (Pubitemid 41058757)
115. Spach KM, Nashold FE, Dittel BN et al. (2006) IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J Immunol 177, 6030-6037. (Pubitemid 44628817)
116. Jeffery LE, Burke F, Mura M et al. (2009) 1,25-dihydroxyvitamin D(3) and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 183, 5458-5467.
117. Urry Z, Xystrakis E, Richards DF et al. (2009) Ligation of TLR9 induced on human IL-10-secreting Tregs by 1a,25-dihydroxyvitamin D3 abrogates regulatory function. J Clin Invest 119, 387-398.
118. Gregori S, Casorati M, Amuchastegui S et al. (2001) Regulatory T cells induced by 1a,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 167, 1945-1953. (Pubitemid 32747499)
119. Dong X, Bachman LA, Kumar R et al. (2003) Generation of antigen-specific, interleukin-10-producing T-cells using dendritic cell stimulation and steroid hormone conditioning. Transpl Immunol 11, 323-333. (Pubitemid 37120551)
120. Adorini L, Penna G, Giarratana N et al. (2004) Dendritic cells as key targets for immunomodulation by vitamin D receptor ligands. J Steroid Biochem Mol Biol 89-90, 437-441. (Pubitemid 38844326)
121. Willheim M, Thien R, Schrattbauer K et al. (1999) Regulatory effects of 1a,25-dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes. J Clin Endocrinol Metab 84, 3739-3744. (Pubitemid 30645234)
122. Veldman CM, Cantorna MT & DeLuca HF (2000) Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 374, 334-338. (Pubitemid 30120270)
123. Iho S, Iwamoto K, Kura F et al. (1990) Mechanism in 1,25(OH)2D3-induced suppression of helper/suppressor function of CD4/CD8 cells to immunoglobulin production in B cells. Cell Immunol 127, 12-25. (Pubitemid 20119661)
124. Cantorna MT, Hayes CE & DeLuca HF (1996) 1,25-dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 93, 7861-7864. (Pubitemid 26277129)
125. Meehan TF & DeLuca HF (2002) CD8( + ) T cells are not necessary for 1a,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Proc Natl Acad Sci USA 99, 5557-5560. (Pubitemid 34411587)
126. Yu S, Bruce D, Froicu M et al. (2008) Failure of T cell homing, reduced CD4/CD8aa intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proc Natl Acad Sci USA 105, 20834-20839.
127. Sigmundsdottir H, Pan J, Debes GF et al. (2007) DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 8, 285-293. (Pubitemid 46745378)
128. Topilski I, Flaishon L, Naveh Y et al. (2004) The antiinflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrinmediated T lymphocyte homing. Eur J Immunol 34, 1068-1076. (Pubitemid 39255985)
129. Shiozawa K, Shiozawa S, Shimizu S et al. (1985) 1a,25-Dihydroxyvitamin D3 inhibits pokeweed mitogen-stimulated human B-cell activation: An analysis using serum-free culture conditions. Immunology 56, 161-167. (Pubitemid 16252423)
130. Provvedini DM, Tsoukas CD, Deftos LJ et al. (1986) 1a,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: Effects on immunoglobulin production. J Immunol 136, 2734-2740. (Pubitemid 16107171)
131. Chen S, Sims GP, Chen XX et al. (2007) Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179, 1634-1647.
132. Holick MF & Chen TC (2008) Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 87, 1080S-1086S. (Pubitemid 351549267)
133. Adorini L & Penna G (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 4, 404-412.
134. Mathieu C, Gysemans C, Giulietti A et al. (2005) Vitamin D and diabetes. Diabetologia 48, 1247-1257. (Pubitemid 41186086)
135. Littorin B, Blom P, Scholin A et al. (2006) Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: Results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 49, 2847-2852. (Pubitemid 44730286)
136. Harris SS (2005) Vitamin D in type 1 diabetes prevention. J Nutr 135, 323-325. (Pubitemid 40194500)
137. Giulietti A, Gysemans C, Stoffels K et al. (2004) Vitamin D deficiency in early life accelerates Type 1 diabetes in nonobese diabetic mice. Diabetologia 47, 451-462. (Pubitemid 38491241)
138. Ramos-Lopez E, Jansen T, Ivaskevicius V et al. (2006) Protection from type 1 diabetes by vitamin D receptor haplotypes. Ann N Y Acad Sci 1079, 327-334. (Pubitemid 44968742)
139. Bailey R, Cooper JD, Zeitels L et al. (2007) Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 56, 2616-2621. (Pubitemid 47523270)
140. Raghuwanshi A, Joshi SS & Christakos S (2008) Vitamin D and multiple sclerosis. J Cell Biochem 105, 338-343.
141. Spach KM & Hayes CE (2005) Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 175, 4119-4126. (Pubitemid 41292076)
142. Spach KM, Pedersen LB, Nashold FE et al. (2004) Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis. Physiol Genomics 18, 141-151. (Pubitemid 39319496)
143. Pedersen LB, Nashold FE, Spach KM et al. (2007) 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J Neurosci Res 85, 2480-2490. (Pubitemid 47204762)
144. Vagianos K, Bector S, McConnell J et al. (2007) Nutrition assessment of patients with inflammatory bowel disease. JPEN J Parenter Enteral Nutr 31, 311-319. (Pubitemid 47025695)
145. Pappa HM, Gordon CM, Saslowsky TM et al. (2006) Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 118, 1950-1961. (Pubitemid 46393676)
146. Pappa HM, Grand RJ & Gordon CM (2006) Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis 12, 1162-1174. (Pubitemid 44847474)
147. Kong J, Zhang Z, Musch MW et al. (2007) Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 294, 2396-2405.
148. Froicu M & Cantorna MT (2007) Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol 8, 5.
149. Froicu M, Weaver V, Wynn TA et al. (2003) A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17, 2386-2392. (Pubitemid 37542204)
150. Lagishetty V, Misharin AV, Liu NQ et al. (2010) Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology 151, 2423-2432.
151. von Essen MR, Kongsbak M, Schjerling P et al. (2010) Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol 11, 344-349.
152. Smolders J, Thewissen M & Damoiseaux J (2011) Control of T cell activation by vitamin D. Nat Immunol 12, 3; author reply 3-4.